These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

379 related items for PubMed ID: 31391345

  • 1. Prohibitin is a prognostic marker and therapeutic target to block chemotherapy resistance in Wilms' tumor.
    Ortiz MV, Ahmed S, Burns M, Henssen AG, Hollmann TJ, MacArthur I, Gunasekera S, Gaewsky L, Bradwin G, Ryan J, Letai A, He Y, Naranjo A, Chi YY, LaQuaglia M, Heaton T, Cifani P, Dome JS, Gadd S, Perlman E, Mullen E, Steen H, Kentsis A.
    JCI Insight; 2019 Aug 08; 4(15):. PubMed ID: 31391345
    [Abstract] [Full Text] [Related]

  • 2. Relapsed Wilms' tumor in pediatric patients: challenges in low- to middle-income countries-a single-center experience.
    Zekri W, Yacoub DM, Ibrahim A, Madney Y.
    J Egypt Natl Canc Inst; 2020 May 01; 32(1):21. PubMed ID: 32372372
    [Abstract] [Full Text] [Related]

  • 3. Urinary hyaluronic acid is a Wilms' tumor marker.
    Lin RY, Argenta PA, Sullivan KM, Stern R, Adzick NS.
    J Pediatr Surg; 1995 Feb 01; 30(2):304-8. PubMed ID: 7738755
    [Abstract] [Full Text] [Related]

  • 4. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM.
    J Clin Oncol; 2006 May 20; 24(15):2352-8. PubMed ID: 16710034
    [Abstract] [Full Text] [Related]

  • 5. Relapse of unilateral favorable histology Wilms' tumor: significant clinicopathological factors.
    Aoba T, Urushihara N, Fukumoto K, Furuta S, Fukuzawa H, Mitsunaga M, Watanabe K, Yamoto M, Miyake H, Koyama M, Iwabuchi H, Koike J, Tatsunami S, Wakisaka M, Kitagawa H.
    J Pediatr Surg; 2012 Dec 20; 47(12):2210-5. PubMed ID: 23217878
    [Abstract] [Full Text] [Related]

  • 6. Association between different levels of lipid metabolism‑related enzymes and fatty acid synthase in Wilms' tumor.
    Wang X, Du G, Wu Y, Zhang Y, Guo F, Liu W, Wu R.
    Int J Oncol; 2020 Feb 20; 56(2):568-580. PubMed ID: 31894270
    [Abstract] [Full Text] [Related]

  • 7. Relapse of Wilms' tumour and detection methods: a retrospective analysis of the 2001 Renal Tumour Study Group-International Society of Paediatric Oncology Wilms' tumour protocol database.
    Brok J, Lopez-Yurda M, Tinteren HV, Treger TD, Furtwängler R, Graf N, Bergeron C, van den Heuvel-Eibrink MM, Pritchard-Jones K, Olsen ØE, de Camargo B, Verschuur A, Spreafico F.
    Lancet Oncol; 2018 Aug 20; 19(8):1072-1081. PubMed ID: 29960848
    [Abstract] [Full Text] [Related]

  • 8. Current challenges in Wilms' tumor management.
    Gommersall LM, Arya M, Mushtaq I, Duffy P.
    Nat Clin Pract Oncol; 2005 Jun 20; 2(6):298-304; quiz 1 p following 324. PubMed ID: 16264987
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of Renal Function in Pediatric Patients After Treatment for Wilms' Tumor.
    Janeczko M, Niedzielska E, Pietras W.
    Adv Clin Exp Med; 2015 Jun 20; 24(3):497-504. PubMed ID: 26467140
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
    Goyal S, Mishra K, Sarkar U, Sharma S, Kumari A.
    Indian J Med Res; 2016 May 20; 143(Supplement):S59-S67. PubMed ID: 27748279
    [Abstract] [Full Text] [Related]

  • 11. [A case of adult Wilms' tumor].
    Hosokawa Y, Saiki S, Hanafusa T, Meguro N, Maeda O, Kinouchi T, Kuroda M, Usami M, Kotake T.
    Hinyokika Kiyo; 2001 Sep 20; 47(9):641-3. PubMed ID: 11692602
    [Abstract] [Full Text] [Related]

  • 12. The prognostic significance of blastemal predominant histology in initially resected Wilms' tumors: a report from the Study Group for Pediatric Solid Tumors in the Kyushu Area, Japan.
    Kinoshita Y, Suminoe A, Inada H, Yagi M, Yanai F, Zaizen Y, Nishi M, Inomata Y, Kawakami K, Matsufuji H, Suenobu S, Handa N, Kohashi K, Oda Y, Hara T, Taguchi T.
    J Pediatr Surg; 2012 Dec 20; 47(12):2205-9. PubMed ID: 23217877
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic and prognostic role of basic fibroblast growth factor in Wilms' tumor patients.
    Lin RY, Argenta PA, Sullivan KM, Adzick NS.
    Clin Cancer Res; 1995 Mar 20; 1(3):327-31. PubMed ID: 9815988
    [Abstract] [Full Text] [Related]

  • 14. Clear cell sarcoma of kidney: A mimicker of Wilms' tumor.
    Aviral G, Sarvesh CM, Sushila J, Ansari MS.
    J Cancer Res Ther; 2023 Mar 20; 19(5):1468-1470. PubMed ID: 37787333
    [Abstract] [Full Text] [Related]

  • 15. The diagnosis and management of Wilms' tumor.
    Green DM.
    Pediatr Clin North Am; 1985 Jun 20; 32(3):735-54. PubMed ID: 2987781
    [Abstract] [Full Text] [Related]

  • 16. Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center.
    Beckwith JB.
    Hum Pathol; 1983 Jun 20; 14(6):481-92. PubMed ID: 6303938
    [Abstract] [Full Text] [Related]

  • 17. Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children.
    Miniati D, Gay AN, Parks KV, Naik-Mathuria BJ, Hicks J, Nuchtern JG, Cass DL, Olutoye OO.
    J Pediatr Surg; 2008 Jul 20; 43(7):1301-7. PubMed ID: 18639686
    [Abstract] [Full Text] [Related]

  • 18. Treatment outcomes in patients less than 2 years of age with small, stage I, favorable-histology Wilms' tumors: a report from the National Wilms' Tumor Study.
    Green DM, Breslow NE, Beckwith JB, Takashima J, Kelalis P, D'Angio GJ.
    J Clin Oncol; 1993 Jan 20; 11(1):91-5. PubMed ID: 8380295
    [Abstract] [Full Text] [Related]

  • 19. Management and outcome of pediatric metastatic Wilms' tumor at the National Cancer Institute, Egypt.
    Elayadi M, Magdy S, Khalil E, Zekri W.
    J Egypt Natl Canc Inst; 2020 Apr 15; 32(1):19. PubMed ID: 32372204
    [Abstract] [Full Text] [Related]

  • 20. Immediate nephrectomy versus preoperative chemotherapy in the management of non-metastatic Wilms' tumour: results of a randomised trial (UKW3) by the UK Children's Cancer Study Group.
    Mitchell C, Pritchard-Jones K, Shannon R, Hutton C, Stevens S, Machin D, Imeson J, Kelsey A, Vujanic GM, Gornall P, Walker J, Taylor R, Sartori P, Hale J, Levitt G, Messahel B, Middleton H, Grundy R, Pritchard J, United Kingdom Cancer Study Group.
    Eur J Cancer; 2006 Oct 15; 42(15):2554-62. PubMed ID: 16904312
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.